103 related articles for article (PubMed ID: 20592366)
21. [The effect of laryngectomy and postoperative radiotheraphy on thyroid gland functions].
Cinar U; Yiğit O; Alkan S; Uslu B; Topuz E; Unsal O; Akgül G; Dadaş B
Kulak Burun Bogaz Ihtis Derg; 2003 Jun; 10(6):226-30. PubMed ID: 13679689
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
23. [An epidemiological study on the relationship between selenium and thyroid function in areas with different iodine intake].
Tong YJ; Teng WP; Jin Y; Li YS; Guan HX; Wang WB; Gao TS; Teng XC; Yang F; Shi XG; Chen W; Man N; Li Z; Guo XJ
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2036-9. PubMed ID: 14703411
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
25. Serum insulin levels and the degree of thyroid dysfunction in hypothyroid women.
Owecki M; El Ali Z; Nikisch E; Sowiński J
Neuro Endocrinol Lett; 2008 Feb; 29(1):137-40. PubMed ID: 18283245
[TBL] [Abstract][Full Text] [Related]
26. [Assessment of the release of thyroid hormones in septic shock--prognostic significance].
Borkowski J; Siemiatkowski A; Wołczyński S; Czaban SL; Jedynak M
Pol Merkur Lekarski; 2005 Jan; 18(103):45-8. PubMed ID: 15859546
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
Wan Nazaimoon WM; Khalid BA
Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
[TBL] [Abstract][Full Text] [Related]
28. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
[TBL] [Abstract][Full Text] [Related]
29. Iron deficiency anaemia in childhood and thyroid function.
Tienboon P; Unachak K
Asia Pac J Clin Nutr; 2003; 12(2):198-202. PubMed ID: 12810411
[TBL] [Abstract][Full Text] [Related]
30. [Thyroid disorders in women with breast cancer].
Hajtmanová E; Muríň P; Kinclová I; Hajtman A; Péč M; Kostková L; Kočišová M
Klin Onkol; 2012; 25(2):124-9. PubMed ID: 22533887
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of women with breast disease using body image drawing analysis.
Eskelinen M; Ollonen P
Anticancer Res; 2010 Jun; 30(6):2399-406. PubMed ID: 20651399
[TBL] [Abstract][Full Text] [Related]
32. Miscarriage, and TNF-α and osteopontin relationship in women patients with Hashimoto's thyroiditis.
Harman E; Karadeniz M; Avci CB; Zengi A; Erdogan M; Yalcin M; Cetinkalp S; Ahmet Gokhan O; Gunduz C; Saygili F; Yilmaz C
Gynecol Endocrinol; 2012 Oct; 28(10):830-3. PubMed ID: 22558919
[TBL] [Abstract][Full Text] [Related]
33. Thyroid disease in relation to breast cancer.
Vorherr H
Klin Wochenschr; 1978 Dec; 56(23):1139-45. PubMed ID: 362055
[TBL] [Abstract][Full Text] [Related]
34. Titin and dystrophin serum concentration changes in patients affected by thyroid disorders.
Zybek-Kocik A; Sawicka-Gutaj N; Domin R; Szczepanek-Parulska E; Krauze T; Guzik P; Ruchała M
Endokrynol Pol; 2021; 72(1):1-7. PubMed ID: 33295636
[TBL] [Abstract][Full Text] [Related]
35. Study on the status of thyroid function and thyroid nodules in chinese breast cancer patients.
Shi Y; Li X; Ran L; Arshad B; Li H; Xu Z; Zhao C; Wu Y; Wu H; Chen H; Li HY; Wu KN; Kong LQ
Oncotarget; 2017 Oct; 8(46):80820-80825. PubMed ID: 29113346
[TBL] [Abstract][Full Text] [Related]
36. A direct relationship between thyroid enlargement and breast cancer.
Smyth PP; Smith DF; McDermott EW; Murray MJ; Geraghty JG; O'Higgins NJ
J Clin Endocrinol Metab; 1996 Mar; 81(3):937-41. PubMed ID: 8772554
[TBL] [Abstract][Full Text] [Related]
37. Thyroid function following breast cancer chemotherapy: A systematic review.
Mortezaee K; Ahmadi A; Haghi-Aminjan H; Khanlarkhani N; Salehi E; Shabani Nashtaei M; Farhood B; Najafi M; Sahebkar A
J Cell Biochem; 2019 Aug; 120(8):12101-12107. PubMed ID: 31021464
[TBL] [Abstract][Full Text] [Related]
38. [Thyroid function in mammary neoplasms].
Pencea V; Gneazdovschi V; Iancu I
Rev Med Chir Soc Med Nat Iasi; 1973; 77(4):801-7. PubMed ID: 4781131
[No Abstract] [Full Text] [Related]
39. Breast cancer. Relationship to thyroid supplements for hypothyroidism.
Kapdi CC; Wolfe JN
JAMA; 1976 Sep; 236(10):1124-7. PubMed ID: 988872
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional thyroid abnormalities in patients with dyshormonal breast disorders and tumors.
Bazyka DA; Lytvynenko O; Bugaistov S
Probl Radiac Med Radiobiol; 2013; (18):156-68. PubMed ID: 25191720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
